Start with the study identifier
An NCT identifier points to a specific ClinicalTrials.gov record. Use that identifier to connect registry details with a publication rather than assuming that matching compound names mean matching trials.
Record the condition, intervention, comparator, planned outcomes, enrollment and dates. Check whether a field describes planned or actual information. These details give context for the question the investigators set out to answer.
Separate the milestones
The trial tracker displays a selected set of registry records and their source dates. It is not a live guarantee of current recruitment or a ranking of treatments.
| Record information | What it means | What it does not prove |
|---|---|---|
| Registered study | A study record exists | A beneficial result |
| Recruitment status | The registry's recorded stage | Availability or suitability for a particular person |
| Completed | The recorded study stage is complete | That a positive result was found |
| Posted results | A results section is available in the registry | Agreement with every promotional claim |
| Journal publication | A report has been published | That its findings apply beyond the studied setting |
Read the registry and paper together
The selected tesamorelin record and its linked published trial show why both sources are useful. Registry metadata describes the study; the paper reports methods and outcomes in more detail.
A registry lacking a posted results section does not necessarily mean no paper was published. Likewise, an abstract online does not automatically identify the final prespecified analysis. Follow the identifiers and source dates.
Check the history, not only the headline
Statuses and records can change. When sharing an interpretation, retain the date checked and distinguish it from the study's own last-update date. A dated source check is more honest than silently presenting an old status as permanently current.
A trial registry is not a medical approval database. The regulatory reference explains why product approval must be checked separately.